FSD Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$18,564,915 over the previous period. Total operating expenses were $17,376,727.
Profit Margin
| 2015 | 0 | -32.8K | |
|---|---|---|---|
| 2016 | 0 | -29.62K | |
| 2017 | 20.63K | -2.80M | -13586.02% |
| 2018 | 65.16K | -16.67M | -25585.94% |
| 2019 | 196.81K | -40.05M | -20350.3% |
| 2020 | 0 | -32.71M | |
| 2021 | 0 | -35.40M | |
| 2022 | 0 | -23.32M | |
| 2023 | 0 | -18.56M |
HUGE Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 0 | 0 | 0 | 0 | 196.81K | 65.16K | 20.63K | 0 | 0 |
Cost of revenue | 2.55M | 4.35M | 4.00M | 4.10M | 2.03M | 0 | 0 | 0 | 0 |
Gross profit | -2.55M | -4.35M | -4.00M | -4.10M | -1.84M | 65.16K | 20.63K | 0 | 0 |
Operating exp. | |||||||||
Research and development | 3.92M | 6.91M | 6.32M | 7.83M | 0 | 0 | 0 | 0 | 0 |
Selling and marketing | 13.43M | 0 | 0 | 0 | 0 | 2.05M | 0 | 0 | 0 |
Total operating expenses | 17.37M | 27.42M | 33.74M | 30.60M | 25.97M | 18.62M | 2.82M | 29.62K | 32.8K |
Operating income | -19.92M | -27.42M | -33.74M | -30.69M | -28.07M | -20.43M | -2.80M | -29.62K | -32.8K |
Other income (expenses), net | 1.36M | 725.94K | -194.29K | 2.23M | -11.74M | 1.88M | 0 | 0 | 0 |
Income before tax | -18.56M | -26.70M | -33.93M | -28.45M | -39.81M | -16.67M | -2.80M | -29.62K | -32.8K |
Income tax expense | -1 | -3.38M | 1.46M | 4.26M | 235.15K | -3.76M | -52.51K | 0 | 0 |
Net income | -18.56M | -23.32M | -35.40M | -32.71M | -40.05M | -16.67M | -2.80M | -29.62K | -32.8K |
Earnings per share | |||||||||
Basic EPS | -0.47 | -0.6 | -1.01 | -2.72 | -5.68 | -2.82 | -0.43 | -0.00 | -0.00 |
Diluted EPS | -0.47 | -0.6 | -1.01 | -2.72 | -5.68 | -2.82 | -0.43 | -0.00 | -0.00 |
| Data source | Data source | Data source |